{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:55:15Z","timestamp":1790009715047,"version":"4.0.1"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012312","name":"Johns Hopkins | SOM, JHU | Robert Packard Center for ALS Research, Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Department of Health & Human Services | U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["1U01FD008129"],"award-info":[{"award-number":["1U01FD008129"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE2139757"],"award-info":[{"award-number":["DGE2139757"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["OAC1920103"],"award-info":[{"award-number":["OAC1920103"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS095969"],"award-info":[{"award-number":["R01NS095969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UH3NS115608"],"award-info":[{"award-number":["UH3NS115608"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R33NS115161"],"award-info":[{"award-number":["R33NS115161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS127186"],"award-info":[{"award-number":["R01NS127186"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62004-5","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:19:35Z","timestamp":1753456775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6440-7019","authenticated-orcid":false,"given":"Irika R.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4452-2400","authenticated-orcid":false,"given":"Parker S.","family":"Sandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-6790","authenticated-orcid":false,"given":"Holly","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace D.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-5156","authenticated-orcid":false,"given":"Aswathy Peethambaran","family":"Mallika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3239-7112","authenticated-orcid":false,"given":"Fatemeh","family":"Abbasinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lourdes F.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaelyn R.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9 Llamas","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-1976","authenticated-orcid":false,"given":"Ben","family":"Langmead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-4079","authenticated-orcid":false,"given":"Jenna M.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-3274","authenticated-orcid":false,"given":"Philip C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-9729","authenticated-orcid":false,"given":"Jonathan P.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"62004_CR1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2777","volume":"10","author":"M Chen","year":"2009","unstructured":"Chen, M. & Manley, J. L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741\u2013754 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62004_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","volume":"136","author":"MC Wahl","year":"2009","unstructured":"Wahl, M. C., Will, C. L. & L\u00fchrmann, R. The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701\u2013718 (2009).","journal-title":"Cell"},{"key":"62004_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470\u2013476 (2008).","journal-title":"Nature"},{"key":"62004_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrm1645","volume":"6","author":"AJ Matlin","year":"2005","unstructured":"Matlin, A. J., Clark, F. & Smith, C. W. J. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6, 386\u2013398 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62004_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Pan, Q., Shai, O., Lee, L. J., Frey, B. J. & Blencowe, B. J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413\u20131415 (2008).","journal-title":"Nat. Genet."},{"key":"62004_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2016.01.029","volume":"164","author":"X Yang","year":"2016","unstructured":"Yang, X. et al. Widespread expansion of protein interaction capabilities by alternative splicing. Cell 164, 805\u2013817 (2016).","journal-title":"Cell"},{"key":"62004_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuron.2015.05.004","volume":"87","author":"B Raj","year":"2015","unstructured":"Raj, B. & Blencowe, B. J. Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles. Neuron 87, 14\u201327 (2015).","journal-title":"Neuron"},{"key":"62004_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41583-023-00717-6","volume":"24","author":"D Nikom","year":"2023","unstructured":"Nikom, D. & Zheng, S. Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat. Rev. Neurosci. 24, 457\u2013473 (2023).","journal-title":"Nat. Rev. Neurosci."},{"key":"62004_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41576-022-00514-4","volume":"23","author":"CJ Wright","year":"2022","unstructured":"Wright, C. J., Smith, C. W. J. & Jiggins, C. D. Alternative splicing as a source of phenotypic diversity. Nat. Rev. Genet. 23, 697\u2013710 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"62004_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrg.2016.46","volume":"17","author":"CR Sibley","year":"2016","unstructured":"Sibley, C. R., Blazquez, L. & Ule, J. Lessons from non-canonical splicing. Nat. Rev. Genet. 17, 407\u2013421 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"62004_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling, J. P., Pletnikova, O., Troncoso, J. C. & Wong, P. C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650\u2013655 (2015).","journal-title":"Science"},{"key":"62004_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.celrep.2016.08.071","volume":"17","author":"JP Ling","year":"2016","unstructured":"Ling, J. P. et al. PTBP1 and PTBP2 repress nonconserved cryptic exons. Cell Rep. 17, 104\u2013113 (2016).","journal-title":"Cell Rep."},{"key":"62004_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1261\/rna.065508.117","volume":"24","author":"SP McClory","year":"2018","unstructured":"McClory, S. P., Lynch, K. W. & Ling, J. P. HnRNP L represses cryptic exons. RNA 24, 761\u2013768 (2018).","journal-title":"RNA"},{"key":"62004_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cell.2012.12.023","volume":"152","author":"K Zarnack","year":"2013","unstructured":"Zarnack, K. et al. Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of alu elements. Cell 152, 453\u2013466 (2013).","journal-title":"Cell"},{"key":"62004_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.39304","volume":"8","author":"I Ehrmann","year":"2019","unstructured":"Ehrmann, I. et al. An ancient germ cell-specific RNA-binding protein protects the germline from cryptic splice site poisoning. eLife 8, e39304 (2019).","journal-title":"eLife"},{"key":"62004_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/1873-3468.14806","volume":"598","author":"M Khan","year":"2024","unstructured":"Khan, M. et al. MATR3 pathogenic variants differentially impair its cryptic splicing repression function. FEBS Lett. 598, 415\u2013436 (2024).","journal-title":"FEBS Lett."},{"key":"62004_CR17","doi-asserted-by":"publisher","first-page":"ddw337","DOI":"10.1093\/hmg\/ddw337","volume":"25","author":"Q Tan","year":"2016","unstructured":"Tan, Q. et al. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum. Mol. Genet. 25, ddw337 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"62004_CR18","doi-asserted-by":"crossref","unstructured":"Carmen-Orozco, R. P. et al. Elevated nuclear TDP-43 induces constitutive exon skipping. Mol. Neurodegener. 18, 45 (2024).","DOI":"10.1101\/2023.05.11.540291"},{"key":"62004_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00178","volume":"2","author":"T Eom","year":"2013","unstructured":"Eom, T. et al. NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. eLife 2, e00178 (2013).","journal-title":"eLife"},{"key":"62004_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1101\/gad.235770.113","volume":"28","author":"M Jangi","year":"2014","unstructured":"Jangi, M., Boutz, P. L., Paul, P. & Sharp, P. A. Rbfox2 controls autoregulation in RNA-binding protein networks. Genes Dev. 28, 637\u2013651 (2014).","journal-title":"Genes Dev."},{"key":"62004_CR21","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/nsmb.2698","volume":"20","author":"PJ Lukavsky","year":"2013","unstructured":"Lukavsky, P. J. et al. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 20, 1443\u20131449 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"62004_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-017-0274-1","volume":"10","author":"J Humphrey","year":"2017","unstructured":"Humphrey, J., Emmett, W., Fratta, P., Isaacs, A. M. & Plagnol, V. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med. Genomics 10, 38 (2017).","journal-title":"BMC Med. Genomics"},{"key":"62004_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-023-00608-5","volume":"18","author":"PR Mehta","year":"2023","unstructured":"Mehta, P. R., Brown, A.-L., Ward, M. E. & Fratta, P. The era of cryptic exons: implications for ALS-FTD. Mol. Neurodegener. 18, 16 (2023).","journal-title":"Mol. Neurodegener."},{"key":"62004_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.14348\/molcells.2023.0003","volume":"46","author":"D Hong","year":"2023","unstructured":"Hong, D. & Jeong, S. 3\u2019UTR diversity: expanding repertoire of RNA alterations in human mRNAs. Mol. Cells 46, 48\u201356 (2023).","journal-title":"Mol. Cells"},{"key":"62004_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"62004_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling, S.-C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416\u2013438 (2013).","journal-title":"Neuron"},{"key":"62004_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00401-024-02705-1","volume":"147","author":"H Spence","year":"2024","unstructured":"Spence, H. et al. RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS. Acta Neuropathol. 147, 50 (2024).","journal-title":"Acta Neuropathol."},{"key":"62004_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00401-023-02653-2","volume":"147","author":"K Chang","year":"2024","unstructured":"Chang, K. et al. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer\u2019s disease neuropathologic changes and cognitive decline. Acta Neuropathol. 147, 4 (2024).","journal-title":"Acta Neuropathol."},{"key":"62004_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ Boer","year":"2021","unstructured":"Boer, E. M. J. et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 92, 86\u201395 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"62004_CR30","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000704","volume":"7","author":"K Masaki","year":"2020","unstructured":"Masaki, K. et al. RNA-binding protein altered expression and mislocalization in MS. Neurol. Neuroimmunol. Neuroinflammation 7, e704 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"62004_CR31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"62004_CR32","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/NEN.0b013e3181ee7d85","volume":"69","author":"AC McKee","year":"2010","unstructured":"McKee, A. C. et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918\u2013929 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"62004_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi, S. et al. Concurrence of TDP-43, tau, and \u03b1-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res. 1184, 284\u2013294 (2007).","journal-title":"Brain Res."},{"key":"62004_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-023-00646-z","volume":"18","author":"VE Ayuso","year":"2023","unstructured":"Ayuso, V. E. et al. TDP-43-regulated cryptic RNAs accumulate in Alzheimer\u2019s disease brains. Mol. Neurodegener. 18, 57 (2023).","journal-title":"Mol. Neurodegener."},{"key":"62004_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol. 127, 441\u2013450 (2014).","journal-title":"Acta Neuropathol."},{"key":"62004_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","volume":"131","author":"KA Josephs","year":"2016","unstructured":"Josephs, K. A. et al. Updated TDP-43 in Alzheimer\u2019s disease staging scheme. Acta Neuropathol. 131, 571\u2013585 (2016).","journal-title":"Acta Neuropathol."},{"key":"62004_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl, C. C. et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 79, 1186 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"62004_CR38","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-016-1637-y","volume":"132","author":"KD LaClair","year":"2016","unstructured":"LaClair, K. D. et al. Depletion of TDP-43 decreases fibril and plaque \u03b2-amyloid and exacerbates neurodegeneration in an Alzheimer\u2019s mouse model. Acta Neuropathol. 132, 859\u2013873 (2016).","journal-title":"Acta Neuropathol."},{"key":"62004_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses, A. et al. TDP-43 pathology in Alzheimer\u2019s disease. Mol. Neurodegener. 16, 84 (2021).","journal-title":"Mol. Neurodegener."},{"key":"62004_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00401-023-02655-0","volume":"147","author":"ARAA Quadros","year":"2024","unstructured":"Quadros, A. R. A. A. et al. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer\u2019s disease. Acta Neuropathol. 147, 9 (2024).","journal-title":"Acta Neuropathol."},{"key":"62004_CR41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mds.30104","volume":"40","author":"SR Pickles","year":"2025","unstructured":"Pickles, S. R. et al. TDP\u201043 cryptic RNAs in perry syndrome: differences across brain regions and TDP\u201043 proteinopathies. Mov. Disord. 40, 662\u2013671 (2025).","journal-title":"Mov. Disord."},{"key":"62004_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-016-0144-x","volume":"12","author":"YH Jeong","year":"2017","unstructured":"Jeong, Y. H. et al. Tdp-43 cryptic exons are highly variable between cell types. Mol. Neurodegener. 12, 13 (2017).","journal-title":"Mol. Neurodegener."},{"key":"62004_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s42003-022-03253-8","volume":"5","author":"U \u0160u\u0161njar","year":"2022","unstructured":"\u0160u\u0161njar, U. et al. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease. Commun. Biol. 5, 314 (2022).","journal-title":"Commun. Biol."},{"key":"62004_CR44","doi-asserted-by":"publisher","first-page":"106245","DOI":"10.1016\/j.nbd.2023.106245","volume":"185","author":"MC Cao","year":"2023","unstructured":"Cao, M. C. et al. A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue. Neurobiol. Dis. 185, 106245 (2023).","journal-title":"Neurobiol. Dis."},{"key":"62004_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS\u2013FTD. Nat. Med. 30, 382\u2013393 (2024).","journal-title":"Nat. Med."},{"key":"62004_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","volume":"19","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E., Sheth, U., Wong, P. C. & Gendron, T. F. Fluid biomarkers for amyotrophic lateral sclerosis: a review. Mol. Neurodegener. 19, 9 (2024).","journal-title":"Mol. Neurodegener."},{"key":"62004_CR47","doi-asserted-by":"publisher","first-page":"eadg7162","DOI":"10.1126\/scitranslmed.adg7162","volume":"16","author":"S Seddighi","year":"2024","unstructured":"Seddighi, S. et al. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD. Sci. Transl. Med. 16, eadg7162 (2024).","journal-title":"Sci. Transl. Med."},{"key":"62004_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/bioinformatics\/btx547","volume":"34","author":"C Wilks","year":"2018","unstructured":"Wilks, C., Gaddipati, P., Nellore, A. & Langmead, B. Snaptron: querying splicing patterns across tens of thousands of RNA-seq samples. Bioinformatics 34, 114\u2013116 (2018).","journal-title":"Bioinformatics"},{"key":"62004_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02533-6","volume":"22","author":"C Wilks","year":"2021","unstructured":"Wilks, C. et al. recount3: summaries and queries for large-scale RNA-seq expression and splicing. Genome Biol. 22, 323 (2021).","journal-title":"Genome Biol."},{"key":"62004_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1118-6","volume":"17","author":"A Nellore","year":"2016","unstructured":"Nellore, A. et al. Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the Sequence Read Archive. Genome Biol. 17, 266 (2016).","journal-title":"Genome Biol."},{"key":"62004_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14020-5","volume":"11","author":"JP Ling","year":"2020","unstructured":"Ling, J. P. et al. ASCOT identifies key regulators of neuronal subtype-specific splicing. Nat. Commun. 11, 137 (2020).","journal-title":"Nat. Commun."},{"key":"62004_CR52","doi-asserted-by":"publisher","first-page":"D19","DOI":"10.1093\/nar\/gkq1019","volume":"39","author":"R Leinonen","year":"2011","unstructured":"Leinonen, R., Sugawara, H., Shumway, M. & Collaboration, I. N. S. D. The sequence read archive. Nucleic Acids Res 39, D19\u2013D21 (2011).","journal-title":"Nucleic Acids Res"},{"key":"62004_CR53","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"T Consortium","year":"2020","unstructured":"Consortium, T. Gte. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"62004_CR54","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"K Chang","year":"2013","unstructured":"Chang, K. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet"},{"key":"62004_CR55","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2016.02.012","volume":"61","author":"B Sundararaman","year":"2016","unstructured":"Sundararaman, B. et al. Resources for the comprehensive discovery of functional RNA elements. Mol. Cell 61, 903\u2013913 (2016).","journal-title":"Mol. Cell"},{"key":"62004_CR56","doi-asserted-by":"publisher","first-page":"D726","DOI":"10.1093\/nar\/gkv1160","volume":"44","author":"CA Sloan","year":"2016","unstructured":"Sloan, C. A. et al. ENCODE data at the ENCODE portal. Nucleic Acids Res 44, D726\u2013D732 (2016).","journal-title":"Nucleic Acids Res"},{"key":"62004_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim, J. R. et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167\u2013179 (2019).","journal-title":"Nat. Neurosci."},{"key":"62004_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180\u2013190 (2019).","journal-title":"Nat. Neurosci."},{"key":"62004_CR59","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma, X. R. et al. TDP-43 represses cryptic exon inclusion in the FTD\u2013ALS gene UNC13A. Nature 603, 124\u2013130 (2022).","journal-title":"Nature"},{"key":"62004_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"A-L Brown","year":"2022","unstructured":"Brown, A.-L. et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131\u2013137 (2022).","journal-title":"Nature"},{"key":"62004_CR61","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1172\/JCI139741","volume":"130","author":"M Prudencio","year":"2020","unstructured":"Prudencio, M. et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Investig. 130, 6080\u20136092 (2020).","journal-title":"J. Clin. Investig."},{"key":"62004_CR62","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn, M. W. et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379, 1140\u20131149 (2023).","journal-title":"Science"},{"key":"62004_CR63","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"62004_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41593-023-01496-0","volume":"27","author":"J L\u00f3pez-Erauskin","year":"2024","unstructured":"L\u00f3pez-Erauskin, J. et al. Stathmin-2 loss leads to neurofilament-dependent axonal collapse, driving motor and sensory denervation. Nat. Neurosci. 27, 34\u201347 (2024).","journal-title":"Nat. Neurosci."},{"key":"62004_CR65","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molmed.2023.12.003","volume":"30","author":"SHV Daele","year":"2024","unstructured":"Daele, S. H. V., Masrori, P., Damme, P. V. & Bosch, L. V. D. The sense of antisense therapies in ALS. Trends Mol. Med. 30, 252\u2013262 (2024).","journal-title":"Trends Mol. Med."},{"key":"62004_CR66","doi-asserted-by":"publisher","first-page":"E3426","DOI":"10.1073\/pnas.1714573115","volume":"115","author":"H Ke","year":"2018","unstructured":"Ke, H. et al. Loss of TDP43 inhibits the progression of triple-negative breast cancer in coordination with SRSF3. Proc. Natl Acad. Sci. 115, E3426\u2013E3435 (2018).","journal-title":"Proc. Natl Acad. Sci."},{"key":"62004_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2013.05.027","volume":"436","author":"C Corbo","year":"2013","unstructured":"Corbo, C., Orr\u00f9, S. & Salvatore, F. SRp20: an overview of its role in human diseases. Biochem. Biophys. Res. Commun. 436, 1\u20135 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62004_CR68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.immuni.2018.05.008","volume":"49","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Iron drives T helper cell pathogenicity by promoting RNA-binding protein PCBP1-mediated proinflammatory cytokine production. Immunity 49, 80\u201392.e7 (2018).","journal-title":"Immunity"},{"key":"62004_CR69","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/blood-2009-03-209965","volume":"114","author":"Y Eberhard","year":"2009","unstructured":"Eberhard, Y. et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 114, 3064\u20133073 (2009).","journal-title":"Blood"},{"key":"62004_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou, L., Jiang, Y., Luo, Q., Li, L. & Jia, L. Neddylation: a novel modulator of the tumor microenvironment. Mol. Cancer 18, 77 (2019).","journal-title":"Mol. Cancer"},{"key":"62004_CR71","first-page":"gkaa1074","volume":"49","author":"D Szklarczyk","year":"2020","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49, gkaa1074 (2020).","journal-title":"Nucleic Acids Res"},{"key":"62004_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30944-x","volume":"13","author":"E Zacco","year":"2022","unstructured":"Zacco, E. et al. Probing TDP-43 condensation using an in silico designed aptamer. Nat. Commun. 13, 3306 (2022).","journal-title":"Nat. Commun."},{"key":"62004_CR73","doi-asserted-by":"publisher","unstructured":"Waldron, F. M. et al. Improved detection of pre-symptomatic, non-central nervous system TDP-43 pathology in amyotrophic lateral sclerosis using RNA aptamer. bioRxiv, https:\/\/doi.org\/10.1101\/2025.04.10.648122 (2025).","DOI":"10.1101\/2025.04.10.648122"},{"key":"62004_CR74","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/prca.201200042","volume":"6","author":"V Thiviyanathan","year":"2012","unstructured":"Thiviyanathan, V. & Gorenstein, D. G. Aptamers and the next generation of diagnostic reagents. Proteom. Clin. Appl. 6, 563\u2013573 (2012).","journal-title":"Proteom. Clin. Appl."},{"key":"62004_CR75","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0738-081X(91)90075-V","volume":"9","author":"BB Abrams","year":"1991","unstructured":"Abrams, B. B., H\u00e4nel, H. & Hoehler, T. Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin. Dermatol. 9, 471\u2013477 (1991).","journal-title":"Clin. Dermatol."},{"key":"62004_CR76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4103\/idoj.IDOJ_29_19","volume":"10","author":"S Sonthalia","year":"2019","unstructured":"Sonthalia, S., Agrawal, M. & Sehgal, V. N. Topical ciclopirox olamine 1%: revisiting a unique antifungal. Indian Dermatol. Online J. 10, 481\u2013485 (2019).","journal-title":"Indian Dermatol. Online J."},{"key":"62004_CR77","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1365-4362.2001.01156.x","volume":"40","author":"AK Gupta","year":"2001","unstructured":"Gupta, A. K. Ciclopirox: an overview. Int. J. Dermatol 40, 305\u2013310 (2001).","journal-title":"Int. J. Dermatol"},{"key":"62004_CR78","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ajh.23640","volume":"89","author":"MD Minden","year":"2014","unstructured":"Minden, M. D. et al. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. Am. J. Hematol. 89, 363\u2013368 (2014).","journal-title":"Am. J. Hematol."},{"key":"62004_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02779-1","volume":"11","author":"J Qi","year":"2020","unstructured":"Qi, J. et al. Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer. Cell Death Dis. 11, 582 (2020).","journal-title":"Cell Death Dis."},{"key":"62004_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03535-9","volume":"12","author":"Z Su","year":"2021","unstructured":"Su, Z. et al. Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK\/p38 MAPK and NF-\u03baB signaling. Cell Death Dis. 12, 251 (2021).","journal-title":"Cell Death Dis."},{"key":"62004_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10200-5","volume":"10","author":"J-A Kang","year":"2019","unstructured":"Kang, J.-A. et al. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly. Nat. Commun. 10, 2184 (2019).","journal-title":"Nat. Commun."},{"key":"62004_CR82","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1101\/gad.188037.112","volume":"26","author":"K Yap","year":"2012","unstructured":"Yap, K., Lim, Z. Q., Khandelia, P., Friedman, B. & Makeyev, E. V. Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. Genes Dev. 26, 1209\u20131223 (2012).","journal-title":"Genes Dev."},{"key":"62004_CR83","first-page":"818","volume":"41","author":"M Zhao","year":"2018","unstructured":"Zhao, M., Kim, J. R., Van Bruggen, R. & Park, J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol. Cells 41, 818\u2013829 (2018).","journal-title":"Mol. Cells"},{"key":"62004_CR84","doi-asserted-by":"publisher","first-page":"653","DOI":"10.15252\/embj.201489852","volume":"34","author":"MB Coelho","year":"2015","unstructured":"Coelho, M. B. et al. Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J. 34, 653\u2013668 (2015).","journal-title":"EMBO J."},{"key":"62004_CR85","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jbiosc.2021.06.015","volume":"132","author":"Y Kato","year":"2021","unstructured":"Kato, Y. & Sakamoto, K. Niclosamide affects intracellular TDP-43 distribution in motor neurons, activates mitophagy, and attenuates morphological changes under stress. J. Biosci. Bioeng. 132, 640\u2013650 (2021).","journal-title":"J. Biosci. Bioeng."},{"key":"62004_CR86","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0021-9258(17)49926-1","volume":"295","author":"F Hans","year":"2019","unstructured":"Hans, F., Glasebach, H. & Kahle, P. J. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J. Biol. Chem. 295, 673\u2013689 (2019).","journal-title":"J. Biol. Chem."},{"key":"62004_CR87","doi-asserted-by":"crossref","unstructured":"Cohen, T. J., Hwang, A. W., Unger, T., Trojanowski, J. Q. & Lee, V. M. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 31, 1241\u20131252 (2012).","DOI":"10.1038\/emboj.2011.471"},{"key":"62004_CR88","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41594-020-00537-7","volume":"28","author":"X Zuo","year":"2021","unstructured":"Zuo, X. et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 28, 132\u2013142 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"62004_CR89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00401-018-1934-8","volume":"137","author":"M Gautam","year":"2019","unstructured":"Gautam, M. et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 137, 47\u201369 (2019).","journal-title":"Acta Neuropathol."},{"key":"62004_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3757","volume":"4","author":"H-Y Chang","year":"2013","unstructured":"Chang, H.-Y., Hou, S.-C., Way, T.-D., Wong, C.-H. & Wang, I.-F. Heat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation. Nat. Commun. 4, 2757 (2013).","journal-title":"Nat. Commun."},{"key":"62004_CR91","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.21037\/qims-20-187","volume":"10","author":"A Bhattarai","year":"2020","unstructured":"Bhattarai, A. et al. Serial assessment of iron in the motor cortex in limb-onset amyotrophic lateral sclerosis using quantitative susceptibility mapping. Quant. Imaging Med. Surg. 10, 1465\u20131476 (2020).","journal-title":"Quant. Imaging Med. Surg."},{"key":"62004_CR92","doi-asserted-by":"publisher","first-page":"e35241","DOI":"10.1371\/journal.pone.0035241","volume":"7","author":"JY Kwan","year":"2012","unstructured":"Kwan, J. Y. et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS ONE 7, e35241 (2012).","journal-title":"PLoS ONE"},{"key":"62004_CR93","doi-asserted-by":"publisher","unstructured":"Gao, J., Okolo, O., Siedlak, S. L., Friedland, R. P. & Wang, X. Ferritin is closely associated with microglia in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. nlae074 https:\/\/doi.org\/10.1093\/jnen\/nlae074 (2024).","DOI":"10.1093\/jnen\/nlae074"},{"key":"62004_CR94","doi-asserted-by":"crossref","unstructured":"Ghaderi, S., Fatehi, F., Kalra, S., Mohammadi, S. & Batouli, S. A. H. Quantitative susceptibility mapping in amyotrophic lateral sclerosis: automatic quantification of the magnetic susceptibility in the subcortical nuclei. Amyotroph. Lateral Scler. Front. Degener. ahead-of-print, 1\u201312 (2024).","DOI":"10.1080\/21678421.2024.2372648"},{"key":"62004_CR95","doi-asserted-by":"publisher","first-page":"618435","DOI":"10.3389\/fnins.2021.618435","volume":"15","author":"P Ravanfar","year":"2021","unstructured":"Ravanfar, P. et al. Systematic review: Quantitative Susceptibility Mapping (QSM) of brain iron profile in neurodegenerative diseases. Front. Neurosci. 15, 618435 (2021).","journal-title":"Front. Neurosci."},{"key":"62004_CR96","doi-asserted-by":"publisher","first-page":"791916","DOI":"10.3389\/fonc.2022.791916","volume":"12","author":"J Yin","year":"2022","unstructured":"Yin, J. et al. Ciclopirox olamine exerts tumor-suppressor effects via topoisomerase II alpha in lung adenocarcinoma. Front. Oncol. 12, 791916 (2022).","journal-title":"Front. Oncol."},{"key":"62004_CR97","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.celrep.2012.12.021","volume":"3","author":"P Belenky","year":"2013","unstructured":"Belenky, P., Camacho, D. & Collins, J. J. Fungicidal drugs induce a common oxidative-damage cellular death pathway. Cell Rep. 3, 350\u2013358 (2013).","journal-title":"Cell Rep."},{"key":"62004_CR98","doi-asserted-by":"publisher","first-page":"590789","DOI":"10.3389\/fncel.2020.590789","volume":"14","author":"S Tang","year":"2020","unstructured":"Tang, S. et al. The role of iron, its metabolism and ferroptosis in traumatic brain injury. Front. Cell. Neurosci. 14, 590789 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"62004_CR99","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa, I. et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol. Ther. 244, 108373 (2023).","journal-title":"Pharmacol. Ther."},{"key":"62004_CR100","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3390\/cells12182318","volume":"12","author":"N Sanghai","year":"2023","unstructured":"Sanghai, N. & Tranmer, G. K. Biochemical and molecular pathways in neurodegenerative diseases: an integrated view. Cells 12, 2318 (2023).","journal-title":"Cells"},{"key":"62004_CR101","doi-asserted-by":"publisher","first-page":"904152","DOI":"10.3389\/fnagi.2022.904152","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Mechanisms of ferroptosis and emerging links to the pathology of neurodegenerative diseases. Front. Aging Neurosci. 14, 904152 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"62004_CR102","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiology.189.3.8234713","volume":"189","author":"H Oba","year":"1993","unstructured":"Oba, H. et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 189, 843\u2013846 (1993).","journal-title":"Radiology"},{"key":"62004_CR103","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0022-510X(95)00205-G","volume":"134","author":"Y Imon","year":"1995","unstructured":"Imon, Y. et al. Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological diseases. J. Neurol. Sci. 134, 27\u201332 (1995).","journal-title":"J. Neurol. Sci."},{"key":"62004_CR104","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/1029842021000045444","volume":"4","author":"D Berg","year":"2002","unstructured":"Berg, D., Becker, G., Riederer, P. & Rie\u00df, O. Iron in neurodegenerative disorders. Neurotox. Res. 4, 637\u2013653 (2002).","journal-title":"Neurotox. Res."},{"key":"62004_CR105","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00415-008-0945-0","volume":"255","author":"EF Goodall","year":"2008","unstructured":"Goodall, E. F., Haque, M. S. & Morrison, K. E. Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients. J. Neurol. 255, 1652\u20131656 (2008).","journal-title":"J. Neurol."},{"key":"62004_CR106","doi-asserted-by":"publisher","first-page":"485723","DOI":"10.1155\/2014\/485723","volume":"2014","author":"C Veyrat-Durebex","year":"2014","unstructured":"Veyrat-Durebex, C. et al. Iron metabolism disturbance in a french cohort of ALS patients. BioMed. Res. Int. 2014, 485723 (2014).","journal-title":"BioMed. Res. Int."},{"key":"62004_CR107","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ane.12708","volume":"136","author":"Y Zheng","year":"2017","unstructured":"Zheng, Y., Gao, L., Wang, D. & Zang, D. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 136, 145\u2013150 (2017).","journal-title":"Acta Neurol. Scand."},{"key":"62004_CR108","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/neup.12763","volume":"41","author":"TT Mitani","year":"2021","unstructured":"Mitani, T. T. et al. Amyotrophic lateral sclerosis with speech apraxia, predominant upper motor neuron signs, and prominent iron accumulation in the frontal operculum and precentral gyrus. Neuropathology 41, 324\u2013331 (2021).","journal-title":"Neuropathology"},{"key":"62004_CR109","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"62004_CR110","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent, W. J. et al. The human genome browser at UCSC. Genome Res 12, 996\u20131006 (2002).","journal-title":"Genome Res"},{"key":"62004_CR111","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"IHGS Consortium","year":"2001","unstructured":"Consortium, I. H. G. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860\u2013921 (2001).","journal-title":"Nature"},{"key":"62004_CR112","doi-asserted-by":"publisher","first-page":"D1082","DOI":"10.1093\/nar\/gkad987","volume":"52","author":"BJ Raney","year":"2023","unstructured":"Raney, B. J. et al. The UCSC Genome Browser database: 2024 update. Nucleic Acids Res 52, D1082\u2013D1088 (2023).","journal-title":"Nucleic Acids Res"},{"key":"62004_CR113","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"62004_CR114","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"62004_CR115","doi-asserted-by":"publisher","unstructured":"Wickham, H. ggplot2, Elegant Graphics for Data Analysis. Use R! 89\u2013107 https:\/\/doi.org\/10.1007\/978-3-319-24277-4_5 (2016).","DOI":"10.1007\/978-3-319-24277-4_5"},{"key":"62004_CR116","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","volume":"104","author":"R Tian","year":"2019","unstructured":"Tian, R. et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron 104, 239\u2013255.e12 (2019).","journal-title":"Neuron"},{"key":"62004_CR117","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.stemcr.2017.08.019","volume":"9","author":"C Wang","year":"2017","unstructured":"Wang, C. et al. Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening. Stem Cell Rep. 9, 1221\u20131233 (2017).","journal-title":"Stem Cell Rep."},{"key":"62004_CR118","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/nprot.2008.133","volume":"3","author":"DJ Korbie","year":"2008","unstructured":"Korbie, D. J. & Mattick, J. S. Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat. Protoc. 3, 1452\u20131456 (2008).","journal-title":"Nat. Protoc."},{"key":"62004_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"62004_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.33","volume":"4","author":"JL Harenza","year":"2017","unstructured":"Harenza, J. L. et al. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci. Data 4, 170033 (2017).","journal-title":"Sci. Data"},{"key":"62004_CR121","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1158\/0008-5472.CAN-19-1504","volume":"79","author":"X Song","year":"2019","unstructured":"Song, X. et al. SRSF3-regulated RNA alternative splicing promotes glioblastoma tumorigenicity by affecting multiple cellular processes. Cancer Res 79, 5288\u20135301 (2019).","journal-title":"Cancer Res"},{"key":"62004_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31228-0","volume":"13","author":"TA Karginov","year":"2022","unstructured":"Karginov, T. A., M\u00e9noret, A. & Vella, A. T. Optimal CD8+ T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape. Nat. Commun. 13, 3540 (2022).","journal-title":"Nat. Commun."},{"key":"62004_CR123","doi-asserted-by":"publisher","unstructured":"Abbasinejad et al. SnapMine. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15624203 (2025).","DOI":"10.5281\/zenodo.15624203"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62004-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:53:54Z","timestamp":1757307234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62004"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62004-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6878"}}